ArticleThe EMBO journal2021
Ythdf is a N6-methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila.
Open access · greenAbstract read
In one paragraph
Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 86 citations in OpenAlex.
- Polyphenism Through RNA Chemical Modifications.Molecular ecology · 2026Review
- The mMolecular psychiatry · 2026Article
- The m⁶A reader YTHDF2 regulates mRNA transport and axon outgrowth in developing neurons.Nature communications · 2026Article
- Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer.Signal transduction and targeted therapy · 2026Review
- Deep learning-assisted discovery of a potent and cell-active inhibitor of RNA NNature communications · 2026Article
- Cocaine remodels mFrontiers in cellular neuroscience · 2026Article
- A rapid and dynamic role for FMRP in the plasticity of adult neurons.Nature communications · 2025Article
- Article
- Loss of Epitranscriptomic Modification NTranslational stroke research · 2025Article
- The role of Chinese herbal medicine in diminished ovarian reserve management.Journal of ovarian research · 2025Review
- Research progress on m6A and drug resistance in gastrointestinal tumors.Frontiers in pharmacology · 2025Review
- Epitranscriptomic control of cancer immunity and therapy resistance.Frontiers in immunology · 2025Review
- The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among mNAR cancer · 2024Article
- Long non-coding RNA CASC15 enhances learning and memory in mice by promoting synaptic plasticity in hippocampal neurons.Exploration (Beijing, China) · 2024Article
- Decoding Nucleotide Repeat Expansion Diseases: Novel Insights fromInternational journal of molecular sciences · 2024Review
- The RNA-binding protein Nab2 regulates levels of the RhoGEF Trio to govern axon and dendrite morphology.Molecular biology of the cell · 2024Article
- Insights into the role of RNA mGenes & diseases · 2024Review
- The YTHDF proteins display distinct cellular functions on mTrends in biochemical sciences · 2024Review
- RNA m6A modification, signals for degradation or stabilisation?Biochemical Society transactions · 2024Review
- RNA modifications in insects.Frontiers in insect science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 7 institutions in 4 countries.
Lina WorpenbergCenter for Integrative Genomics, Génopode Building, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Chiara PaolantoniCenter for Integrative Genomics, Génopode Building, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Sara LonghiLaboratory of Translational Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Miriam M MulorzInstitute of Molecular Biology (IMB), Mainz, Germany.
Tina LenceInstitute of Molecular Biology (IMB), Mainz, Germany.ORCID 0000-0001-9377-546X
Hans-Hermann WesselsMax Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.ORCID 0000-0001-5551-404X
Erik DassiLaboratory of RNA Regulatory Networks, Department CIBIO, University of Trento, Trento, Italy.
Giuseppe AielloArmenise-Harvard Laboratory of Brain Disorders and Cancer, Department CIBIO, University of Trento, Trento, Italy.ORCID 0000-0001-8723-2127
F X Reymond SutandyInstitute of Molecular Biology (IMB), Mainz, Germany.
Marion ScheibeInstitute of Molecular Biology (IMB), Mainz, Germany.
Raghu R EdupugantiDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
Anke BuschBioinformatics Core Facility, IMB, Mainz, Germany.
Martin M MöckelProtein Production Core Facility, IMB, Mainz, Germany.
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.ORCID 0000-0003-0836-6894
Falk ButterInstitute of Molecular Biology (IMB), Mainz, Germany.ORCID 0000-0002-7197-7279
Julian KönigInstitute of Molecular Biology (IMB), Mainz, Germany.
Michela NotarangeloLaboratory of Translational Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Uwe OhlerMax Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.ORCID 0000-0002-0881-3116
Christoph DieterichKlaus Tschira Institute for Integrative Computational Cardiology and Department of Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0001-9468-6311
Alessandro QuattroneCenter for Integrative Genomics, Génopode Building, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-3333-7630
Alessia SoldanoLaboratory of Translational Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0002-3120-9929
Jean-Yves RoignantCenter for Integrative Genomics, Génopode Building, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1395-2150
Institute of Molecular Biology · DEUniversity of Trento · ITMax Delbrück Center · DERadboud University Nijmegen · NLUniversity of Lausanne · CHHeidelberg University · DEJohannes Gutenberg University Mainz · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
N6-methyladenosine (m
Indexed as
AdenosineAnimalsAxonsDrosophila melanogasterDrosophila ProteinsFragile X Messenger Ribonucleoprotein 1NeuronsRNA-Binding ProteinsRNA, MessengerAdenosineDrosophila ProteinsFMR1 protein, DrosophilaFragile X Messenger Ribonucleoprotein 1N-methyladenosineRNA-Binding ProteinsRNA, MessengerFmr1m6Anervous systemRNA modificationYthdf
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.